• Inauguration et mise en service d’une installation polyvalente de pointe pour la fabrication de conjugués anticorps-médicaments (ADC) qui augmente la capacité d’environ 70 à 80 % • Adrian Gillespie, directeur général de Scottish Enterprise, se joint à l’équipe de direction de Piramal et…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.